An analysis of the costs and benefits of the rule was conducted by the Food and Drug Administration ( FDA ) and published in the notice of proposed rulemaking on August 11 , 1995 , and is contained in the preamble to the final rule .
The FDA concluded that the rule would not be practical to enforce .